| dc.creator | Alonso, Daniel Fernando | |
| dc.creator | Vázquez, Ana María | |
| dc.creator | Alonso, Daniel Fernando | |
| dc.creator | Macías, Amparo | |
| dc.date.accessioned | 2015-12-28T17:59:57Z | |
| dc.date.available | 2015-12-28T17:59:57Z | |
| dc.date.created | 2015-12-28T17:59:57Z | |
| dc.date.issued | 2013-02-26 | |
| dc.identifier | Alonso, Daniel Fernando; Vázquez, Ana María; Alonso, Daniel Fernando; Macías, Amparo; Anti-idiotype antibodies in cancer treatment; Frontiers Media S.A.; Frontiers in Oncology; 3; 26-2-2013; 1 | |
| dc.identifier | 2234-943X | |
| dc.identifier | http://hdl.handle.net/11336/3241 | |
| dc.description.abstract | Anti-idiotype antibodies (anti-Id Abs) are antibodies to idiotopes that are located in the variable region, including the antigen binding site, of another antibody. When the last is the case, these anti-Id Abs can act as surrogates of the original antigen. The capability of anti-Id Abs to modulate the immune response has been the basis for the development of anti-Id vaccines against different antigens, including tumor-associated antigens. Over the years, its use in cancer has been demonstrated as effective and promising. | |
| dc.language | eng | |
| dc.publisher | Frontiers Media S.A. | |
| dc.relation | info:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fonc.2013.00037/full | |
| dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3389/fonc.2013.00037 | |
| dc.relation | info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581801/ | |
| dc.rights | https://creativecommons.org/licenses/by/2.5/ar/ | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Anti-Idiotype Antibodies | |
| dc.subject | Cancer Treatment | |
| dc.title | Anti-idiotype antibodies in cancer treatment | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
